Prime Capital Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.27M | Sell |
12,319
-1,401
| -10% | -$125K | 0.01% | 475 |
|
|
2026
Q1 | $985K | Sell |
13,720
-848
| -6% | -$65.3K | 0.01% | 508 |
|
|
2025
Q4 | $1.16M | Sell |
14,568
-332
| -2% | -$26.2K | 0.01% | 460 |
|
|
2025
Q3 | $1.12M | Sell |
14,900
-98
| -0.7% | -$6.72K | 0.01% | 458 |
|
|
2025
Q2 | $1.03M | Sell |
14,998
-2,638
| -15% | -$173K | 0.01% | 465 |
|
|
2025
Q1 | $1.19M | Buy |
17,636
+1,207
| +7% | +$72.2K | 0.01% | 464 |
|
|
2024
Q4 | $737K | Sell |
16,429
-18,778
| -53% | -$1.05M | 0.01% | 481 |
|
|
2024
Q3 | $2.21M | Sell |
35,207
-14,523
| -29% | -$847K | 0.03% | 298 |
|
|
2024
Q2 | $2.94M | Sell |
49,730
-30,121
| -38% | -$1.88M | 0.04% | 266 |
|
|
2024
Q1 | $6.37M | Sell |
79,851
-37,889
| -32% | -$2.89M | 0.09% | 174 |
|
|
2023
Q4 | $9.3M | Buy |
117,740
+48,709
| +71% | +$3.47M | 0.14% | 130 |
|
|
2023
Q3 | $4.82M | Sell |
69,031
-20,237
| -23% | -$1.43M | 0.1% | 160 |
|
|
2023
Q2 | $6.17M | Buy |
89,268
+14,655
| +20% | +$1.04M | 0.12% | 137 |
|
|
2023
Q1 | $5.54M | Buy |
74,613
+2,366
| +3% | +$198K | 0.23% | 89 |
|
|
2022
Q4 | $6.73M | Buy |
72,247
+13,353
| +23% | +$1.29M | 0.26% | 82 |
|
|
2022
Q3 | $5.62M | Buy |
58,894
+27,007
| +85% | +$2.67M | 0.32% | 65 |
|
|
2022
Q2 | $2.96M | Buy |
31,887
+22,326
| +234% | +$2.18M | 0.18% | 100 |
|
|
2022
Q1 | $986K | Hold |
9,561
| – | – | 0.05% | 173 |
|
|
2021
Q4 | $986K | Sell |
9,561
-18,154
| -66% | -$1.68M | 0.05% | 177 |
|
|
2021
Q3 | $2.35M | Buy |
27,715
+19,524
| +238% | +$1.64M | 0.15% | 119 |
|
|
2021
Q2 | $683K | Buy |
8,191
+3,541
| +76% | +$290K | 0.04% | 219 |
|
|
2021
Q1 | $350K | Sell |
4,650
-32,073
| -87% | -$2.34M | 0.03% | 215 |
|
|
2020
Q4 | $2.51M | Buy |
36,723
+955
| +3% | +$62.1K | 0.19% | 99 |
|
|
2020
Q3 | $2.09M | Sell |
35,768
-10,415
| -23% | -$648K | 0.18% | 104 |
|
|
2020
Q2 | $3M | Buy |
46,183
+30,123
| +188% | +$1.9M | 0.28% | 69 |
|
|
2020
Q1 | $953K | Buy |
16,060
+15,144
| +1,653% | +$1.01M | 0.11% | 116 |
|
|
2019
Q4 | $68K | Sell |
916
-80,954
| -99% | -$5.68M | 0.01% | 278 |
|
|
2019
Q3 | $5.16M | Sell |
81,870
-4,090
| -5% | -$242K | 0.8% | 28 |
|
|
2019
Q2 | $4.68M | Sell |
85,960
-10,795
| -11% | -$581K | 0.85% | 30 |
|
|
2019
Q1 | $5.22M | Sell |
96,755
-10,386
| -10% | -$641K | 1.52% | 14 |
|
|
2018
Q4 | $7.02M | Buy |
107,141
+4,797
| +5% | +$358K | 2.54% | 7 |
|
|
2018
Q3 | $8.06M | Buy |
102,344
+43,139
| +73% | +$3.08M | 2.56% | 6 |
|
|
2018
Q2 | $3.81M | Buy |
59,205
+52,005
| +722% | +$3.43M | 1.6% | 17 |
|
|
2018
Q1 | $448K | Sell |
7,200
-38,200
| -84% | -$2.74M | 0.32% | 64 |
|
|
2017
Q4 | $3.29M | Buy |
+45,400
| New | +$3.3M | 2.54% | 7 |
|
Other funds holding CVS
Prime Capital Investment Advisors's CVS Position: Q2 2026 in Review
Prime Capital Investment Advisors reduced its CVS Health (CVS) stake by 10% in Q2 2026, selling an estimated $125K and leaving 12,319 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #475.
Prime Capital Investment Advisors first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. The position peaked at $9.3M in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Prime Capital Investment Advisors held 12,319 shares of CVS Health worth $1.27M as of Q2 2026.
- Prime Capital Investment Advisors sold 1,401 CVS Health shares in Q2 2026, an estimated $125K.
- CVS Health made up 0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #475 holding.
- Prime Capital Investment Advisors first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- Prime Capital Investment Advisors's CVS Health position peaked at $9.3M in Q4 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.